Belgian-based UCB said Thursday it plans to buy Ra Pharmaceuticals, a Cambridge company which is developing treatments for rare diseases, for about $2.5 billion. UCB is paying $48 a share, more than double Ra’s closing price Wednesday.
See Original Article

The school board is setting aside up to $50,000 to pay an accounting firm to examine the books from the last few years. The non-audit examination will
See Original Article

Shares of Aphria (NYSE:APHA), Canopy Growth (NYSE:CGC), and Tilray (NASDAQ:TLRY) were sinking by 13.8%, 9.9%, and 12.6%, respectively, as of 3:15 p.m. EDT on Thursday. All three felt the brunt of a general sell-off of Canadian marijuana stocks after …
See Original Article

It’s been a rough fall for Kenny & Zuke’s, the classic Portland deli with locations across the city: Less than a month after announcing plans to file for bankruptcy, owner Ken Gordon broke the news today that Kenny & Zuke’s Bagelworks, the Northwest Portland …
See Original Article

TOKYO (Reuters) – Toyota Motor Corp (7203.T) unveiled a completely redesigned hydrogen-powered fuel cell sedan on Friday in its latest attempt to revive demand for the niche technology that it hopes will become mainstream. FILE PHOTO: The logo of …
See Original Article